Roxana Mehran learns more from Annapoorna Kini about her work to understand stable CAD plaque morphology, with the latest trial focused on the effects of PCSK9 inhibitors.
Dr. George and the Columbia Valve team discussed new technology from the two largest structural heart companies, the Edwards SAPIEN X4 and the Medtronic Evolut FX.
Don't miss the best and most up-to-date content for our CHIP community.